Nitrous oxide analgesia during retinopathy screening: a randomised controlled trial

Authors:

Abstract
Objectives: To determine if the addition of an inhaled equimolar mixture of nitrous oxide (N2O) and oxygen (EMONO) would produce superior pain relief to standard pharmacological and non-pharmacological measures during eye examination screening for retinopathy of prematurity (ROP) in premature infants. Study design: A randomised, double-blind controlled trial was conducted. Setting: Royal Victoria Hospital, a tertiary neonatal intensive care unit in Montreal, Canada. Patients: Stable spontaneously breathing premature infants with birth weights less than 1500 g or gestation of 30 weeks and less. Intervention: During the eye examination, all infants were swaddled, received oral sucrose and topical anaesthetics. Control group infants received a mixture of 50% oxygen and 50% nitrogen (n=18) administered by nasal cannula, while the intervention group received EMONO (50% oxygen and 50% N2O). Main outcome measures: Pain was assessed by the premature infant pain profile (PIPP). Results: The mean PIPP score at speculum insertion in the control group (8.4, 95% CI 7.6 to 9.3) was comparable with the EMONO group (8.5, 95% CI 7.3 to 9.8) with a p value of 0.94. There were no significant differences in heart rate or saturation between the two groups. EMONO inhalation was tolerated without any measured side effects. Conclusion: EMONO does not produce any additional pain relief over currently used measures during ROP screening eye examinations. Systematically combining pharmacological and non-pharmacological treatment modalities appears to be the best option until newer treatments are proven effective. Clinical trials registration number: NCT00623220

This publication has 30 references indexed in Scilit: